• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Implantable Cardioverter-Defibrillators (ICDs) may be reused after explantation

bys25qthea
October 24, 2012
in Cardiology, Infectious Disease, Surgery
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD

Key study points:

  1. There were no  infectious complications after the implantation of the used and resterilized implantable cardioverter defibrillators (ICD).
  2. Only 2 out of the 106 reimplanted ICDs were replaced because of ventricular lead dislodgment and due to multiple inappropriate shocks.

Primer: Implantable Cardioverter-Defibrillators (ICDs) have been a mainstay therapy to treat ventricular arrhythmias, heart failure (ejection fraction < 35%), and sudden cardiac death. These devices sense electrical activity in the heart, and when appropriate, deliver an electrical burst into the cardiac muscle to try to re-establish normal automaticity. In lower income nations, the rate of implantation of ICDs is much lower than higher income nations because of the high cost of the device. Although many ICDs have a battery life of 6 to 10 years, many of these devices are either replaced or no longer needed after 4 years in the United States. The purpose of this article was to explore whether it was possible to reuse viable ICDs in patients who could not regularly afford them.

Background reading: 

  1. Tan TC, Sindone AP, Denniss AR. Cardiac electronic implantable devices in the treatment of heart failure. Heart, Lung and Circulation 2012;21:338-351.

This [observational] study: The authors collected and implanted a total of 106 ICDs. These ICDs were obtained from patients around the United States from regional funeral homes, from patients who were receiving newer ICDs or were explanted due to infection. Explanted ICDs needed to have a battery voltage of at least 3.0 volts or more than 3 years of battery life. Recipients in India who received these devices needed to have a class I indication for ICD placement.

81 patients received 106 ICDs since 2002. After the implantation, there was no indication of any infection of the resterilized devices. Only 2 out of the 106 units were replaced due to malfunction; one was due to a dislodged lead and the other was due to multiple inappropriate shocks. The ICDs needed to be replaced within a mean time of 1287.4 days (range: 125 to 2108 days). As a result, 22 patients received a second device and 3 received a third device. 9 out of 81 patients were lost to follow up due to death. 60.4% of 106 ICDs provided proper treatment in 54.3% of patients.

In sum: The study examined whether explanted ICD devices could be sterilized and reused in a low-income population. The authors demonstrated that reused ICDs were not associated with any infectious complications after surgery and that these devices were able to deliver appropriate treatment. This study illustrates that many explanted ICDs that are functional can be reused in a population who cannot afford the device. The authors note that this strategy could be used within the United States –devices retrieved from upgrades, infections or death could be given to the uninsured. However, certain legislations would need to be put in place in order to protect liable parties.

RELATED REPORTS

Lisocabtagene maraleucel improves survival for relapsed or refractory large B-cell lymphoma

Fazirsiran reduces Z-AAT protein production in alpha1-antitrypsin deficiency

Arterial chemoembolization improves survival in non-resectable hepatocellular carcinoma [Classics Series]

There are several limitations to this study. Only 2 physicians performed all of the implantations and this was at only one center in India. Therefore, this data may not be very generalizable to larger populations. Furthermore, only a small number of devices and small population were used in this study. To see whether this may be a feasible option, further research would need to include more patients and more devices. Last, the authors did not calculate whether the implantation of the ICDs were cost-effective. However, the strengths of this study were that it showed that even after extensive handling and time between explantation and implantation, these devices still delivered proper treatment. Future research needs to expand the population and number of devices to see whether this strategy is feasible.

 Click to read the study in Annals of Internal Medicine

 By [JC] and [MP]

 © 2012 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. DISCLAIMER: Posts are not medical advice and are not intended as such. Please see a healthcare professional if you seek medical advice.

 

Previous Post

Linezolid treats Chronic Extensively Drug-Resistant TB but has a high incidence of adverse effects

Next Post

A molecular link between sleep deprivation and insulin resistance

RelatedReports

Mutation linked with decrease in cutaneous diffuse large B-cell lymphoma
Chronic Disease

Lisocabtagene maraleucel improves survival for relapsed or refractory large B-cell lymphoma

June 29, 2022
Novel combination therapy may be effective for noncirrhotic HCV infection [UNITY-1 trial]
Chronic Disease

Fazirsiran reduces Z-AAT protein production in alpha1-antitrypsin deficiency

June 29, 2022
The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
Hematology/Oncology Classics

Arterial chemoembolization improves survival in non-resectable hepatocellular carcinoma [Classics Series]

June 29, 2022
#VisualAbstract: Varenicline improves successful smoking cessation amongst African American daily smokers: KIS-IV Trial
StudyGraphics

#VisualAbstract: Anti-tau antibody Semorinemab not shown to slow clinical progression of Alzheimer’s disease

June 29, 2022
Next Post

A molecular link between sleep deprivation and insulin resistance

Meta-analysis suggests novel oral anticoagulants might be safer than warfarin for atrial fibrillation

Annual seminar helps surgery residents prepare for future management roles

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Lisocabtagene maraleucel improves survival for relapsed or refractory large B-cell lymphoma
  • Fazirsiran reduces Z-AAT protein production in alpha1-antitrypsin deficiency
  • Arterial chemoembolization improves survival in non-resectable hepatocellular carcinoma [Classics Series]
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.